Effectiveness of regdanvimab on mortality in COVID-19 infected patients on hemodialysis

Effectiveness of regdanvimab on mortality in COVID-19 infected patients on hemodialysis

Background Although several therapeutic agents have been evaluated for the treatment of coronavirus disease 2019 (COVID-19), there are lack of effective and proven treatments for end-stage renal disease (ESRD). The present study aims to evaluate the effectiveness of regdanvimab on mortality in COVID...

Full description

Bibliographic Details
Main Authors: Youn Kyung Kee, Hayne Cho Park, Su Jin Yoon, Sungbong Yu, Eunsil Ko, AJin Cho, Do Hyoung Kim, Jinseog Kim, Young-Ki Lee
Format: Article
Language:English
Published: The Korean Society of Nephrology 2024-01-01
Series:Kidney Research and Clinical Practice
Subjects:
covid-19
renal dialysis
mortality
regdanvimab
Online Access:http://krcp-ksn.org/upload/pdf/j-krcp-23-137.pdf

Internet

http://krcp-ksn.org/upload/pdf/j-krcp-23-137.pdf

Similar Items